Cancer High-Risk Subjects Identified by Serum Pepsinogen Tests: Outcomes after 10-Year Follow-up in Asymptomatic Middle-Aged Males

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2008-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-07-2762PMID 18398025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum Pepsinogens in Gastric Cancer Screening

  2010cited by this paper
• Feasibility and cost‐effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow‐up of patients with atrophic chronic gastritis and intestinal metaplasia

  2007cited by this paper
• Helicobacter pylori infection and gastric cancer.

  2006cited by this paper
• Gastric cancer screening of a high‐risk population in Japan using serum pepsinogen and barium digital radiography

  2005influential reference
• Screening for gastric cancer

  2005cited by this paper
• Helicobacter pylori and molecular events in precancerous gastric lesions

  2004cited by this paper
• International variation

  2004cited by this paper
• Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening

  2004cited by this paper
• Comparison of stomach cancer incidence and survival in four continents.

  2003cited by this paper
• Usefulness of Gastric Cancer Screening Using the Serum Pepsinogen Test Method

  2003cited by this paper
• Gastric cancer and Helicobacter pylori

  2002cited by this paper
• The epidemiology of gastric cancer.

  2002cited by this paper
• Diagnosis of gastritis by means of a combination of serological analyses.

  2002cited by this paper
• Screening for gastric cancer in Japan

  2000cited by this paper
• Accuracy of screening for gastric cancer using serum pepsinogen concentrations

  1999cited by this paper
• Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan.

  1997cited by this paper
• Helicobacter pylori Infection and Gastric Cancer (A Nested Case-Control Study in a Rural Area of Japan)

  1997cited by this paper
• The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.

  1997cited by this paper
• Helicobacter pylori serology in patients with chronic gastritis.

  1996cited by this paper
• Serum pepsinogen in screening for gastric cancer

  1995cited by this paper
• The evaluation of screening for gastric cancer in miyagi prefecture, Japan: A population‐based case‐control study

  1995cited by this paper
• [Epidemiological evaluation of the protective effect for dying of stomach cancer by screening programme for stomach cancer with applying a method of case-control study--a study of a efficient screening programme for stomach cancer].

  1995cited by this paper
• Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens

  1995cited by this paper
• Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma.

  1993cited by this paper
• Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality

  1993cited by this paper
• Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer

  1993influential reference
• Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study

  1993cited by this paper
• Gastric cancer and Helicobacter pylori

  1993cited by this paper
• Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.

  1992influential reference
• Risk of leukemia among participants of gastric mass screening survey in Japan: a population-based, case-control study.

  1992cited by this paper
• Histogenesis of intestinal and diffuse types of gastric carcinoma.

  1991cited by this paper
• The Significance of Low Serum Pepsinogen Levels to Detect Stomach Cancer Associated with Extensive Chronic Gastritis in Japanese Subjects

  1989cited by this paper
• Serum pepsinogens as a screening test of extensive chronic gastritis

  1987cited by this paper
• Serum pepsinogens I and II and stomach cancer.

  1987cited by this paper
• Evaluation of a mass screening program for stomach cancer with a case‐control study design

  1986cited by this paper
• Mass screening for gastric cancer by X-ray examination.

  1984cited by this paper
• Precursors of gastric and esophageal cancer.

  1982cited by this paper
• Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders.

  1982cited by this paper
• Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.

  1982cited by this paper
• Mass survey of gastric cancer and leukemia in Miyagi Prefecture, Japan.

  1982cited by this paper
• Evaluation of a mass screening program for stomach cancer.

  1979cited by this paper
• Screening for gastric cancer in Japan.

  1978cited by this paper
• THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

  1965influential reference

• Helicobacter pylori-Related Chronic Gastritis as a Risk Factor for Lower Bone Mineral Density

  2025influential citation
• Predictors of the Development of Gastric Cancer in Post-Helicobacter pylori-Eradication Patients Followed Up for More than 10 Years: A Histological, Serological, and Endoscopic Study

  2025influential citation
• Current Status of Gastric Cancer Screening and Future Perspectives

  2025influential citation
• Global progress and future prospects of early gastric cancer screening

  2024cites this paper
• Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)

  2024cites this paper
• Study on the Clinical Value of Serum Pepsinogen II in Gastritis Detection

  2023cites this paper
• Pepsinogen ratio and brachial-ankle pulse wave velocity: a cross-sectional study on their interrelationship in atherosclerosis

  2023cites this paper
• A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area

  2023cites this paper
• Guidelines for diagnosis and treatment of chronic gastritis in China (2022, Shanghai)

  2023cites this paper
• The Differences of Pepsinogen I and H. Pylori Levels in Patients With Gastric Premalignant Lesion

  2022cites this paper
• Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001

  2022cites this paper
• Forthcoming Step in Gastric Cancer Prevention: How Can Risk Stratification Be Combined with Endoscopic Screening for Gastric Cancer?

  2022cites this paper
• Analysis of long-term serological and histological changes after eradication of Helicobacter pylori

  2022cites this paper
• Gastric Cancer in Iran: An Overview of Risk Factors and Preventive Measures.

  2021cites this paper
• Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer.

  2021cites this paper
• Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients

  2021cites this paper
• Predictive value of nomogram based on Kyoto classification of gastritis to diagnosis of gastric cancer

  2021cites this paper
• Gastric cancer: Epidemiology, risk factors and prevention strategies

  2020cites this paper
• Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review

  2020cites this paper
• Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy

  2019influential citation
• Diagnostic performance of serum pepsinogen assay for the prediction of atrophic gastritis and gastric neoplasms

  2019cites this paper
• Diagnosis and Treatment of Superficial Gastric Neoplasms

  2019cites this paper
• Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea

  2019cites this paper
• Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer

  2019cites this paper
• S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL

  2019cites this paper
• Clinical significance of serum markers reflecting gastric function and H. pylori infection in colorectal cancer

  2019cites this paper
• Chinese consensus on chronic gastritis (2017, Shanghai)

  2018cites this paper
• Factors Affecting Endoscopic Curative Resection of Gastric Cancer in the Population-Based Screening Era

  2018cites this paper
• Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area

  2018cites this paper
• Association between VEGF-634G>C Gene Polymorphism with Gastric Premalignant Lesions and Serum VEGF Levels in Helicobacter pylori Gastritis Patients

  2018cites this paper
• Update version of the Japanese Guidelines for Gastric Cancer Screening.

  2018cites this paper
• Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study

  2017cites this paper
• Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody.

  2017cites this paper
• The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions

  2017cites this paper
• Clinical values of gastrin 17 and pepsinogen in gastric cancer and precancerous lesion screening

  2017cites this paper
• Abomasal dysfunction and cellular and mucin changes during infection of sheep with larval or adult Teladorsagia circumcincta

  2017cites this paper
• Western long-term accuracy of serum pepsinogen-based gastric cancer screening

  2017cites this paper
• Natural Course of Helicobacter pylori Infection in Japanese Hemodialysis Patients

  2017cites this paper
• A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study

  2017cites this paper
• Gastric Cancer as Preventable Disease

  2017cites this paper
• Atrophic Gastritis and Intestinal Metaplasia

  2016cites this paper
• Screening and surveillance for gastric cancer in the United States: Is it needed?

  2016cites this paper
• [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

  2016cites this paper
• Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels - The ABC Method

  2016cites this paper
• Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection

  2016cites this paper
• Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.

  2016cites this paper
• Relationship between ghrelin, Helicobacter pylori and gastric mucosal atrophy in hemodialysis patients

  2016cites this paper
• Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection

  2016cites this paper
• Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer

  2016cites this paper
• S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease

  2016cites this paper
• Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer

  2015cites this paper
• Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?

  2015cites this paper
• Emerging blood-based biomarkers for detection of gastric cancer.

  2015cites this paper
• Helicobacter pylori Antibody Titer and Gastric Cancer Screening

  2015influential citation
• Diagnosis and Management of High Risk Group for Gastric Cancer

  2015cites this paper
• Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: A longitudinal study

  2015cites this paper
• Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis

  2015cites this paper
• Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer

  2014cites this paper
• Current issues and future perspectives of gastric cancer screening.

  2014cites this paper
• Advanced Method for Evaluation of Gastric Cancer Risk By Serum Markers: Determination of True Low‐Risk Subjects for Gastric Neoplasm

  2014cites this paper
• Implementation of gastric cancer screening - the global experience.

  2014cites this paper
• Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms.

  2014cites this paper
• Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.

  2014cites this paper
• Molecular diagnostics in gastric cancer.

  2014cites this paper
• The progress of experimental research on the Chinese medicine treatment for chronic atrophic gastritis

  2014cites this paper
• Prevalence of gastric precancerous conditions: a systematic review and meta-analysis

  2014cites this paper
• Gastric cancer: prevention, screening and early diagnosis.

  2014cites this paper
• Risk Factors of Chronic Atrophic Gastritis

  2014cites this paper
• Biomarkers for Gastric Cancer and the Related Premalignant Conditions

  2014cites this paper
• Gastric Cancer Risk Diagnosis Using Molecular Biological and Serological Markers Based on Helicobacter pylori-Related Chronic Gastritis

  2013cites this paper
• Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.

  2013cites this paper
• Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis

  2013influential citation
• Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori

  2013cites this paper
• Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: A follow-up study of patients with endoscopically resected colorectal neoplasia.

  2013cites this paper
• Diagnosis and Staging of Diseases of the Stomach

  2013cites this paper
• Optimal cutoff value of the serum pepsinogen level for prediction of gastric cancer incidence: the Hisayama Study

  2012cites this paper
• Serum pepsinogen test for early detection of gastric cancer in a European Country

  2012cites this paper
• Recent development of gastric cancer prevention.

  2012cites this paper
• Aberrant Methylation of RASGRF1 Is Associated with an Epigenetic Field Defect and Increased Risk of Gastric Cancer

  2012cites this paper
• Aberrant Methylation of RASGRF 1 Is Associated with an Epigenetic Field Defect and IncreasedRisk of Gastric Cancer

  2012cites this paper
• Serological assessment of gastric mucosal atrophy in gastric cancer

  2012cites this paper
• Helicobacter pylori: clinical management

  2012cites this paper
• Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

  2012influential citation
• Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis

  2012influential citation
• Direct Measurement of Gastroesophageal Reflux Episodes in Patients With Squamous Cell Carcinoma by 24-h pH-Impedance Monitoring

  2011cites this paper
• A C to T polymorphism of urokinase plasminogen activator (P141L) is associated with Helicobacter pylori infection.

  2011cites this paper
• Gastric Cancer Risk Diagnosis and Prevention in Subjects with Helicobacter pylori-related Chronic Gastritis

  2011influential citation
• Incidence and risk factors for the development of chronic atrophic gastritis: Five year follow‐up of a population‐based cohort study

  2011cites this paper
• Reduced serum vascular endothelial growth factor receptor‐2 (sVEGFR‐2) and sVEGFR‐1 levels in gastric cancer patients

  2011cites this paper
• Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer.

  2011cites this paper
• Transnasal and standard transoral endoscopies in the screening of gastric mucosal neoplasias.

  2011cites this paper
• Elevated risk of colorectal adenoma with Helicobacter pylori‐related chronic gastritis: A population‐based case‐control study

  2011cites this paper
• Histological evaluation of patients with gastritis at high risk of developing gastric cancer using a conventional index.

  2011cites this paper
• S3-Leitlinie „Magenkarzinom” –

  2011cites this paper
• Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”

  2011cites this paper
• Clinical and biological markers in gastric cancer: update and perspectives.

  2010cites this paper
• No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese

  2010influential citation
• Smoking behavior and risk of Helicobacter pylori infection, gastric atrophy and gastric cancer in Japanese.

  2010influential citation
• The Serum Pepsinogen Test and Stratifying Patients at Risk for Gastric Cancer.

  2010cites this paper
• No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese

  2010influential citation